You are here:
Home » PART 3 MANAGEMENT AND ACCOUNTABILITY » Operational planning

Operational planning

The NBA has established a comprehensive three year planning framework (2013-16) as depicted in Figure 3.2. The NBA Operational Plan outlines the supporting work program for the third year of this framework and is structured to align with the goals and objectives identified in the approved JBC Strategic Plan 2013-15 and NBA Corporate Plan 2013-16. Other key documents the work program takes into account include:

  • JBC-approved National Blood Sector Data and Information Strategy and Scorecard 2013-2016
  • JBC-approved National Blood Sector ICT Strategy 2013-2016
  • JBC-approved National Blood and Blood Product Wastage Reduction Strategy 2013-2017
  • JBC-approved National Patient Blood Management Guidelines Implementation Strategy 2013-2017
  • National Blood Sector Education and Training Strategy 2013-2016
  • NBA Risk Management Register
  • National Blood Sector Research and Development Statement of Priorities 2013-16.

Progress against the Operational Plan is monitored and reported on by Executive Members and the General Manager on a quarterly basis. The quarterly report on progress against key actions is provided to the NBA Board and Audit Committee.

NBA Operational Planning Diagram

FIGURE 3.2 NBA Planning Framework

In 2015-16, the NBA delivered 97 per cent of activities against the planned outcomes. Table 3.1 demonstrates the overall trend in the NBA's delivery against our operational plans over the past five years.

TABLE 3.1 NBA's performance in achieving operational plan objectives, 2011–12 to 2015–16

Year 2011–12 2012–13 2013-14 2014–15 2015-16
Performance (%) 87% 91% 96% 91% 97%

Key operational achievements for 2015-16 included the following:

  • the uninterrupted supply of blood and blood products to meet all clinical demand in accordance with the approved NSP&B
  • negotiated a new Deed of Agreement with the Australian Red Cross Society signed on 20 February 2016
  • national blood sector research and development pilot implemented for funding of research and development activities in the blood sector
  • NBA continued work with the ACSQHC on the revision of the NSQHS Standards in particular Standard 7 revision to be implemented in 2018
  • Ig Governance program implemented and supports all supply authorisation for Ig, and new Ig governance system BloodSTAR roll out
  • the publication of national PBM Guidelines Module 6 on Neonatal and Paediatrics
  • release of National Haemophilia Guidelines to Australian Haemophilia Centre Directors' Organisation (AHCDO)
  • implementation of BloodNet enhancements and continued Laboratory Information Systems (LIS) interfaces
  • publication of a range of data reports including the Report on the Issue and Use of Intravenous Immunoglobulin (IVIg) 2014-15, Australian Haemovigilance Report and the Australian Bleeding Disorders Registry Annual Report 2014-15.
Back to Top